enVVeno Medical Corp Segments Disclosure
Note 14 – Segment Reporting
The Company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. Since the Company operates in a single segment, the measure of segment total assets and loss from operations is the same as that reported on the accompanying balance sheets as total assets, and the accompanying statement of operations as loss from operations, respectively.
The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM uses operating expenses to measure performance against progress in its clinical trials and its product development. The following table sets forth segment expenses.
For the Years Ended December 31, |
||||||||
| (In thousands) | 2025 | 2024 | ||||||
| Research and Development: | ||||||||
| Employee expense | $ | 5,339 | $ | 4,984 | ||||
| Clinical | 3,216 | 5,345 | ||||||
| Product | 840 | 1,147 | ||||||
| Other | 586 | 773 | ||||||
| Total research and development | 9,981 | 12,249 | ||||||
| Selling, general and administrative expense | ||||||||
| Employee expense | 6,147 | 6,285 | ||||||
| Professional fees | 1,558 | 2,451 | ||||||
| Occupancy | 597 | 626 | ||||||
| Insurance | 610 | 655 | ||||||
| Other | 2,006 | 1,560 | ||||||
| Total selling, general and administrative expense | 10,918 | 11,577 | ||||||
| Loss from operations | 20,899 | 23,826 | ||||||
| Adjustments and reconciling items | (1,427 | ) | (2,007 | ) | ||||
| Net loss | $ | 19,472 | $ | 21,819 | ||||
Adjustments and reconciling items in the above table consist of interest income and realized and unrealized gains and losses related to our investments in U.S. Treasury securities.
Want the next enVVeno Medical Corp segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment enVVeno Medical Corp's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.